113 related articles for article (PubMed ID: 36244905)
1. Modifying the Composite Time Trade-Off Method to Improve Its Discriminatory Power.
Jakubczyk M; Lipman SA; Roudijk B; Norman R; Pullenayegum E; Yang Y; Gu NY; Stolk E
Value Health; 2023 Feb; 26(2):280-291. PubMed ID: 36244905
[TBL] [Abstract][Full Text] [Related]
2. Re-revisiting the Utilities of Health States Worse than Dead: The Problem Remains.
Jakubczyk M
Med Decis Making; 2023; 43(7-8):875-885. PubMed ID: 37846095
[TBL] [Abstract][Full Text] [Related]
3. Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology.
Lipman SA; Zhang L; Shah KK; Attema AE
Eur J Health Econ; 2023 Mar; 24(2):293-305. PubMed ID: 35596831
[TBL] [Abstract][Full Text] [Related]
4. How different are composite and traditional TTO valuations of severe EQ-5D-5L states?
Xie F; Pullenayegum E; Gaebel K; Bansback N; Bryan S; Ohinmaa A; Poissant L; Johnson JA
Qual Life Res; 2016 Aug; 25(8):2101-8. PubMed ID: 26875190
[TBL] [Abstract][Full Text] [Related]
5. Censoring in the time trade-off valuation of worse-than-dead EQ-5D-5L health states: can a time-based willingness-to-accept question be the solution?
Liao M; Rand K; Yang Z; Hsu CN; Lin HW; Luo N
Qual Life Res; 2023 Apr; 32(4):1165-1174. PubMed ID: 36564637
[TBL] [Abstract][Full Text] [Related]
6. A threshold explanation for the lack of variation in negative composite time trade-off values.
Roudijk B; Donders R; Stalmeier P
Qual Life Res; 2022 Sep; 31(9):2753-2761. PubMed ID: 35622295
[TBL] [Abstract][Full Text] [Related]
7. Correcting for discounting and loss aversion in composite time trade-off.
Lipman SA; Attema AE; Versteegh MM
Health Econ; 2022 Aug; 31(8):1633-1648. PubMed ID: 35474364
[TBL] [Abstract][Full Text] [Related]
8. A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada.
Xie F; Pullenayegum E; Gaebel K; Bansback N; Bryan S; Ohinmaa A; Poissant L; Johnson JA;
Med Care; 2016 Jan; 54(1):98-105. PubMed ID: 26492214
[TBL] [Abstract][Full Text] [Related]
9. Estimating Utility Values for Health States of DFU Patients Using EQ-5D-5L and cTTO.
Arab-Zozani M; Safari H; Dori Z; Afshari S; Ameri H; Namiranian N; Hoseini E; Jafari A
Int J Low Extrem Wounds; 2022 Mar; 21(1):41-49. PubMed ID: 33939495
[TBL] [Abstract][Full Text] [Related]
10. Using Time Trade-Off Values to Estimate EQ-5D-Y Value Sets: An Exploratory Study.
Yang Z; Jiang J; Wang P; Wu J; Fang Y; Feng D; Xi X; Luo N
Value Health; 2023 Jul; 26(7):968-973. PubMed ID: 36921897
[TBL] [Abstract][Full Text] [Related]
11. Testing "Pits" Time Trade-Off: Can Data Quality be Improved by Removing Death From Valuation of Health States?
Liao M; Yang Z; Rand K; Luo N
Value Health; 2024 May; ():. PubMed ID: 38795961
[TBL] [Abstract][Full Text] [Related]
12. The effect of duration and time preference on the gap between adult and child health state valuations in time trade-off.
Lang Z; Attema AE; Lipman SA
Eur J Health Econ; 2024 Jun; 25(4):601-613. PubMed ID: 37420133
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan.
Shiroiwa T; Ikeda S; Noto S; Igarashi A; Fukuda T; Saito S; Shimozuma K
Value Health; 2016; 19(5):648-54. PubMed ID: 27565282
[TBL] [Abstract][Full Text] [Related]
14. Peruvian Valuation of the EQ-5D-5L: A Direct Comparison of Time Trade-Off and Discrete Choice Experiments.
Augustovski F; Belizán M; Gibbons L; Reyes N; Stolk E; Craig BM; Tejada RA
Value Health; 2020 Jul; 23(7):880-888. PubMed ID: 32762989
[TBL] [Abstract][Full Text] [Related]
15. Comparison of online and face-to-face valuation of the EQ-5D-5L using composite time trade-off.
Jiang R; Shaw J; Mühlbacher A; Lee TA; Walton S; Kohlmann T; Norman R; Pickard AS
Qual Life Res; 2021 May; 30(5):1433-1444. PubMed ID: 33247810
[TBL] [Abstract][Full Text] [Related]
16. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.
Ferreira PL; Antunes P; Ferreira LN; Pereira LN; Ramos-Goñi JM
Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730
[TBL] [Abstract][Full Text] [Related]
17. Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary.
Rencz F; Brodszky V; Gulácsi L; Golicki D; Ruzsa G; Pickard AS; Law EH; Péntek M
Value Health; 2020 Sep; 23(9):1235-1245. PubMed ID: 32940242
[TBL] [Abstract][Full Text] [Related]
18. A Head-On Ordinal Comparison of the Composite Time Trade-Off and the Better-Than-Dead Method.
Roudijk B; Donders ART; Stalmeier PFM
Value Health; 2020 Feb; 23(2):236-241. PubMed ID: 32113629
[TBL] [Abstract][Full Text] [Related]
19. Value Set for the EQ-5D-Y-3L in Hungary.
Rencz F; Ruzsa G; Bató A; Yang Z; Finch AP; Brodszky V
Pharmacoeconomics; 2022 Dec; 40(Suppl 2):205-215. PubMed ID: 36123448
[TBL] [Abstract][Full Text] [Related]
20. United States Valuation of EQ-5D-5L Health States Using an International Protocol.
Pickard AS; Law EH; Jiang R; Pullenayegum E; Shaw JW; Xie F; Oppe M; Boye KS; Chapman RH; Gong CL; Balch A; Busschbach JJV
Value Health; 2019 Aug; 22(8):931-941. PubMed ID: 31426935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
